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NF-jB Inhibition Reveals Differential Mechanisms
of TNF Versus TRAIL-Induced Apoptosis Upstream
or at the Level of Caspase-8 Activation Independent
of cIAP2
Philip Diessenbacher1, Mike Hupe1, Martin R. Sprick2,3, Andreas Kerstan4, Peter Geserick1, Tobias L. Haas2,
Tina Wachter3, Manfred Neumann5, Henning Walczak2, John Silke6 and Martin Leverkus1
Death ligands not only activate a death program but also regulate inflammatory signalling pathways, for
example, through NF-kB induction. Although tumor necrosis factor (TNF)-related apoptosis-inducing ligand
(TRAIL) and TNF both activate NF-kB in human keratinocytes, only TRAIL potently induces apoptosis. However,
when induction of NF-kB was inhibited with a kinase dead IKK2 mutant (IKK2-KD), TNF- but not TRAIL-induced
apoptosis was dramatically enhanced. Acquired susceptibility to TNF-induced apoptosis was due to increased
caspase-8 activation. To investigate the mechanism of resistance of HaCaT keratinocytes to TNF-induced
apoptosis, we analyzed a panel of NF-kB-regulated effector molecules. Interestingly, the inhibitor of apoptosis
protein (IAP) family member cIAP2, but not cIAP1, X-linked inhibitor of apoptosis, TNF receptor-associated
factor (TRAF)-1, or TRAF2, was downregulated in sensitive but not in resistant HaCaT keratinocytes. Surprisingly,
however, stable inducible expression of cIAP2 was not sufficient to render IKK2-KD-sensitized keratinocytes
resistant to TNF, and reduction of cIAP2 alone did not increase the sensitivity of HaCaT keratinocytes to TNF. In
conclusion, we demonstrate that inhibition of NF-kB dramatically sensitizes human keratinocytes to TNF- but
not to TRAIL-induced apoptosis and that this sensitization for TNF was largely independent of cIAP2. Our data
thus clearly exclude the candidates proposed to date to confer TNF apoptosis resistance and suggest the
function of an unanticipated effector of NF-kB critical for the survival of HaCaT keratinocytes upstream or at the
level of caspase-8 activation.
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INTRODUCTION
Apoptosis is a highly regulated physiological process that is
critical for tissue homeostasis and is initiated by a plethora of
physiological and pathophysiological stimuli, such as UV
irradiation, growth factor deprivation, or chemotherapeutic
drugs (Danial and Korsmeyer, 2004; Kroemer et al., 2005).
Based on the nature of the initiating stimulus, apoptotic
signalling pathways have been generally distinguished
as ‘‘intrinsic’’ or ‘‘extrinsic’’ (Sprick and Walczak, 2004).
The so-called extrinsic pathway is initiated by ligation
of death receptors whose ligands such as tumor necrosis
factor (TNF), CD95L (Fas ligand), and TNF-related apop-
tosis-inducing ligand (TRAIL) are all members of the
TNF superfamily (Locksley et al., 2001). They have been
studied intensively over the past decade, and their role
in activation-induced cell death, autoimmune disorders,
immune privilege, and tumor evasion from the immune
system is now well established (reviewed in Wallach
et al., 1999; Ashkenazi, 2002; Debatin and Krammer,
2004). TRAIL and CD95L are mainly considered pro-
apoptotic ligands that act by facilitating recruitment of the
adaptor protein Fas-associated death domain protein (FADD)
and activation of the initiator caspases 8 and 10 to form a
‘‘death-inducing signalling complex,’’ the so-called DISC.
Activated initiator caspases process and activate effector
caspases, which ultimately cause cell death (Sprick and
Walczak, 2004).
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TNF, in contrast, has more pleiotropic functions (for
review, see Wajant et al., 2003). TNF binds to two different
membrane-bound receptors, TNF-R1 and TNF-R2. However,
TNF binding initially promotes recruitment of TNF receptor-
associated death domain (TRADD), receptor-interacting
protein-1 (RIP-1), and TNF receptor-associated factor
(TRAF)-2 to the membrane-associated TNF-R1, which results
in activation of NF-kB and pro-survival signalling (Zhang
et al., 2000) but does not lead to recruitment of either FADD
or caspase-8 (Harper et al., 2003; Micheau and Tschopp,
2003). Following an initial burst of pro-survival signalling, the
membrane-associated signalling complex dissociates and
reassembles in the cytoplasm with FADD and caspase-8,
and caspase-8 becomes subsequently activated (Micheau and
Tschopp, 2003). In nearly all cases, the initial pro-survival
signalling from the membrane-associated complex is suffi-
cient to protect cells from the subsequent formation of the
pro-apoptotic caspase-8-containing complex, which addi-
tionally contains components of the IKK complex required for
activation of NF-kB, another important function of TNF
(Zhang et al., 2000).
Based on the observation that inhibition of NF-kB is
required to sensitize cells to TNF-induced apoptosis, it has
been widely accepted that NF-kB target genes are responsible
for the maintenance of resistance to TNF-induced apoptosis.
The inhibitors of apoptosis protein, cIAP1 and cIAP2, were
originally identified as TNF-R2-associated proteins (Rothe
et al., 1995). Furthermore, cIAP1/2 and the closely related
X-linked inhibitor of apoptosis (XIAP) are targets of NF-kB
signalling pathways (for review, see Karin and Lin, 2002).
XIAP, in particular, is a well-characterized caspase inhibitor.
For these reasons, it has long been suspected and claimed
that the upregulation of cIAP1/2 following TNF signalling is
responsible, either partially or in its entirety, for the
protection afforded by the initial burst of pro-survival
signalling (Wang et al., 1998). However, owing to technical
difficulties and lack of tools, it has been extremely difficult to
prove or disprove this hypothesis. Therefore, the exact
mechanism of resistance to TNF-mediated apoptosis has not
been elucidated so far.
Keratinocytes express all the components required to
execute the apoptotic program, and the intricate balance
between apoptotic and nonapoptotic signals may be crucial
for the outcome of death receptor triggering in the skin
(Leverkus et al., 2003a; Marconi et al., 2004; Iordanov et al.,
2005). Furthermore, the role of death receptors such as TNF-
R1, CD95, TRAIL-R1, or TRAIL-R2 in keratinocytes is well
established in vitro and has been confirmed in several
knockout models (for review, see Wehrli et al., 2000).
Pathological modulation of apoptosis signalling in the skin
can lead to skin cancer or inflammatory diseases like
psoriasis or alopecia areata (for review, see Weisfelner and
Gottlieb, 2003; Giannetti et al., 2004). In this regard, it is
significant that induction of apoptosis by keratinocyte-
derived CD95L has been suggested to represent an important
pathogenic factor for toxic epidermal necrolysis (Viard et al.,
1998), whereas TNF or CD95L is implicated in keratinocyte
apoptosis following UVB irradiation (Schwarz et al., 1995;
Leverkus et al., 1997). Importantly, inhibition of TNF
signalling shows clinical benefit for inflammatory diseases
like psoriasis, indicating its importance in the pathophysio-
logical context of skin diseases. Our previous reports have
demonstrated that inhibition of NF-kB activation does not
sensitize keratinocytes to apoptosis induction by the death
ligand TRAIL, while effectively interfering with TRAIL-
induced NF-kB activation and the induction of its target
genes. These data suggested that gene induction is a distinct
apoptosis-independent signal elicited by TRAIL receptors in
the skin (Leverkus et al., 2003a, b).
In this report, we compared the mechanisms governing the
sensitivity to TNF-mediated versus TRAIL-induced apoptosis.
We first show that inhibition of NF-kB dramatically sensitized
HaCaT keratinocytes to TNF-induced apoptosis. We then
demonstrate that TNF-induced apoptosis is inhibited up-
stream or at the level of caspase-8 activation as it was
efficiently blocked by the long form of c-FLICE inhibitory
protein (cFLIPL). Upon analysis of a larger panel of anti-
apoptotic NF-kB target genes, we found a specific and
significant reduction in the expression of cIAP2, whereas the
levels of cIAP1, TRAF1, TRAF2, or cFLIP were not affected.
Surprisingly, however, selective downregulation of cIAP2 by
small interfering RNA (siRNA) did not sensitize HaCaT
keratinocytes to TNF, and inducible lentiviral expression of
cIAP2 in IKK2-kinase dead (KD)-expressing HaCaT keratino-
cytes was not sufficient to re-establish TNF resistance. In
contrast to the most commonly accepted model (Karin and
Lin, 2002; Burstein and Duckett, 2003), our data show that
although NF-kB inhibition is a prerequisite for sensitization to
TNF-induced apoptosis, the regulated expression of cIAP2
alone is not sufficient to maintain resistance to TNF in the
absence of constitutive or induced NF-kB activity. Further-
more, they strongly suggest that at least one other NF-kB
target gene that acts upstream or at the level of caspase-8
must be important to maintain resistance to TNF-induced
apoptosis.
RESULTS
Modulation of NF-jB activity by IKK2 mutants in human HaCaT
keratinocytes
We recently showed that inhibition of NF-kB did not modify
the sensitivity to TRAIL-induced apoptosis in keratinocytes
(Leverkus et al., 2003a). To test the impact of modulation of
NF-kB activity on TNF responses in human skin, we
generated HaCaT keratinocyte cell lines carrying either KD
or constitutively active (EE) mutants of IKK2. Western blot
analysis confirmed expression of the high and comparable
expression of the respective molecules in HaCaT cells as
compared to low levels of expression of the wild-type kinase
in control-infected cells (Figure 1a). IKK2-KD expression
resulted in complete inhibition of basal as well as either
TRAIL- or TNF-induced NF-kB DNA binding (Figure 1b). As
expected, IKK2-EE-expressing HaCaT keratinocytes showed
high basal NF-kB DNA binding and no further induction
upon treatment with TRAIL or TNF (Figure 1b). These
bulk-infected HaCaT keratinocytes were examined for
apoptosis induction following stimulation with TRAIL or
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TNF, measuring the percentage of cells with hypodiploid
DNA content by propidium iodide staining (Figure 2).
Consistent with our previous data (Leverkus et al., 2003a),
the prominent sensitivity to TRAIL-induced apoptosis was not
modified by ectopic expression of mutants of IKK2 (Figure
2a), and TRAIL-treated cells showed an identical dose-
dependent kill curve as vector cells (Figure 2b). In contrast,
TNF triggering of vector-infected cells revealed their resis-
tance to TNF-induced apoptosis. Strikingly, resistance to
TNF-induced apoptosis is abrogated in IKK2-KD-expressing
HaCaT keratinocytes, whereas expression of IKK2-EE had no
effect on the extent of TNF-mediated apoptosis as compared
to vector cells (Figure 2). When we used inducible expression
of IKK2 mutants, very similar results were obtained, strongly
arguing against a cell culture artifact occurring during the
selection procedure (Figure S3). Taken together, our data
suggested that sensitivity to TNF-induced apoptosis is
regulated by NF-kB, but plays a negligible role in TRAIL-
mediated apoptosis in HaCaT keratinocytes.
Activation of caspases during TNF- and TRAIL-induced cell
death
To investigate the mechanism responsible for the loss of
resistance to TNF-mediated cell death in IKK2-KD-expressing
HaCaT keratinocytes, we analyzed the activation of caspases
following TNF or TRAIL treatment (Figure 3). In control cells,
as well as in IKK2-KD-expressing HaCaT keratinocytes,
processing of caspase-8 was readily detectable following
TRAIL stimulation within 120minutes (Figure 3a, lanes
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Figure 1. Overexpression of IKK2 mutants in human HaCaT keratinocytes.
(a) HaCaT keratinocytes were retrovirally transduced with IKK2-KD, IKK2-EE,
or control vector as described in Materials and Methods. A total of 20 mg
protein of total cellular lysates was separated by western blotting and
subsequently analyzed for expression of IKK2. Tubulin served as a loading
control. (b) Suppression and constitutive activation of NF-kB in IKK2-KD- and
IKK2-EE-expressing cells. Pools of infected HaCaT keratinocytes were either
left untreated or stimulated with 1 mgml1 TRAIL or TNF for 1 hour, harvested,
and protein content was estimated in triplicate. Subsequently, nuclear extracts
were analyzed for kB-specific DNA binding by electrophoretic mobility shift
assay. The positions of p65/p50 heterodimers or p50 homodimers are
indicated and were confirmed using supershift analysis in separate
experiments (Figure S1b).
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Figure 2. Overexpression of IKK2-KD, but not IKK2-EE leads to sensitization
to TNF-mediated apoptosis in HaCaT keratinocytes. (a) TNF-induced
apoptosis of IKK2-KD-expressing HaCaT keratinocytes. Pools of infected cells
were either left untreated or stimulated with 1mgml1 TRAIL or 1 mgml1
TNF for 6 hours, harvested, and examined for the induction of apoptosis
using hypodiploidy analysis. (b) Dose-dependent induction of TNF- or
TRAIL-mediated cell death in IKK2 mutant-expressing HaCaT keratinocytes.
Pools of infected cells were either left untreated or stimulated with increasing
concentrations of TRAIL or TNF for 16–24 hours. Viability was examined by
crystal violet staining. The mean7SD of a total of four independent
experiments is shown.
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15–28). In contrast, caspase processing was undetectable in
TNF-stimulated control cells, whereas IKK2-KD HaCaT cells
showed cleavage of caspase-8, cFLIP (detectable upon
prolonged exposure), and the main effector caspase-3 with
delayed kinetics only after 240–360minutes (Figure 3a, lanes
1–14). Moreover, a marked upregulation of cFLIPS and a slight
increase in cFLIPL expression was detectable following TNF
stimulation for 4–6 hours in an NF-kB-dependent manner
(Figure 3a, lanes 1–14). It was theoretically possible that TNF
induced upregulation of other death ligands such as TRAIL or
CD95L and that these ligands killed IKK2-KD cells in an
autocrine loop. Such autocrine induction of apoptosis could
explain the 2-hour delay in caspase activation during TNF-
mediated cell death (Figure 3a, lane 13) is compared to
TRAIL-mediated cell death (Figure 3a, lanes 19 and 26). To
test this hypothesis, we performed experiments in the
presence of receptor fusion proteins (TNF-R2-Fc, CD95-Fc,
and TRAIL-R2-Fc). We found that TNF-induced cell death in
NF-kB-inhibited cells was fully blocked by the addition of
TNF-R2-Fc. Although TRAIL-R2-Fc and CD95-Fc proteins
were able to block TRAIL- and CD95L-mediated cell death
and therefore were fully biologically active, they were unable
to prevent TNF-induced cell death (Figure 3b), excluding the
possibility that TNF-induced cell death is mediated by
autocrine production of CD95L or TRAIL. It remained
possible that higher death receptor expression in the
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Figure 3. TNF stimulation of IKK2-KD-transduced HaCaT keratinocytes leads to caspase-8 and caspase-3 cleavage with delayed kinetics. (a) TNF-induced
caspase-8, caspase-10, and cFLIP cleavage. Cells expressing IKK2-KD or control vector-infected cells were incubated for the indicated times with TRAIL or
TNF (both at 1 mgml1) and subsequently analyzed for cleavage of caspase-8 (p43/p41/p18), cFLIP (p43), and caspase-3 by western blot (WB). (b) Autocrine
secretion of death ligands such as TRAIL or CD95L is not responsible for TNF-induced cell death. Pools of infected HaCaT keratinocytes were either left
untreated or stimulated with TRAIL, TNF, or CD95L (all at 1 mgml1) for 16–24 hours in the presence or absence of TNF-R2-Fc, TRAIL-R2-Fc, or CD95-Fc
(all at 10 mgml1). Cell viability was determined by crystal violet staining. The mean7SD of a total of two independent experiments is shown. TNF-induced
cell death in NF-kB-inhibited cells was fully blocked by the addition of TNF-R2-Fc (Enbrel), whereas TRAIL-R2-Fc and CD95-Fc were ineffective. Control
cultures incubated with TRAIL or CD95L showed effective inhibition of CD95L- or TRAIL-mediated cell death by these reagents.
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IKK2-KD cells determined increased sensitivity to TNF. We
therefore characterized expression of TRAIL and TNF surface
receptors. Consistent with our previous reports (Leverkus
et al., 2003a; Wachter et al., 2004), control HaCaT cells
expressed TRAIL-R1 and TRAIL-R2 and barely detectable
levels of TNF-R1 and TNF-R2 on the cell surface (Figure S2a).
IKK2-KD-expressing cells showed similar levels of these
receptors when compared to controls (Figure S2a). IKK2-EE-
expressing HaCaT cells showed higher surface expression
levels of TRAIL-R1, as well as TRAIL-R2, TNF-R1, and TNF-
R2, in agreement with a previous report that NF-kB induces
TRAIL death receptor expression (Ravi et al., 2001). Yet,
IKK2-EE-expressing cells were as resistant to TNF-mediated cell
death as control cells, despite higher expression levels of
TNF-R1 and TNF-R2. Conversely, IKK2-KD cells, if anything,
expressed slightly less TNF-R1 and TNF-R2 than control cells,
but they were markedly more sensitive to TNF-induced cell
death than their respective controls. Taken together, these data
demonstrate that receptor expression is not the major determi-
nant of TNF apoptosis sensitivity in HaCaT keratinocytes.
cFLIP differentially affects TNF- and TRAIL-induced apoptosis
signalling
cFLIP is a crucial inhibitor of CD95 or TRAIL-R1/2 signalling
pathways, and mouse embryonic fibroblasts from cFLIP-
deficient animals are highly sensitive to TNF-induced
apoptosis (Yeh et al., 2000). Basal levels of cFLIP were
not detectably changed in IKK2-KD-expressing HaCaT
cells when compared to control cells. However, cFLIPL
(55 kDa) and cFLIPS (25 kDa) were slightly induced in an
NF-kB-dependent manner within 4–6 hours of TNF treatment
(compare Figure 3a, lanes 1–14), suggesting that cFLIP may
be a crucial factor for TNF apoptosis resistance as reported
(Kreuz et al., 2001; Micheau et al., 2001). To further explore
the impact of cFLIP on TNF-induced cell death in keratino-
cytes, we next sequentially expressed both cFLIPL and IKK2-
KD in HaCaT keratinocytes. In line with our previous results,
cFLIP efficiently inhibited TRAIL-induced apoptosis (Wachter
et al., 2004). Notably, TNF-induced cell death (Figure 4a) as
well as TNF-induced caspase-8 and caspase-3 cleavage was
largely inhibited upon overexpression of cFLIPL (Figure 4b).
Interestingly, in cells expressing cFLIPL, cleavage of cFLIPL to
the p43 fragment was detectable only when basal or induced
NF-kB activation was inhibited by expression of IKK2-KD,
indicating that in these cells caspase activity is sufficient for
cFLIPL cleavage, but not for allowing sufficient effector
caspase activation required for apoptosis induction. Thus,
as expected, expression of high levels of cFLIP is sufficient for
TRAIL and TNF apoptosis resistance. To further explore the
dynamic requirement of cFLIP for TNF resistance, we infected
HaCaT keratinocytes with retroviral siRNA against cFLIP.
Successfully infected cells were selected for a short time and
analyzed for TRAIL- or TNF-mediated caspase-8 activation as
well as apoptosis sensitivity. Of note, the expression of a
retroviral control construct alone increased basal cFLIP
expression in HaCaT keratinocytes (data not shown). None-
theless, cFLIP siRNA sensitized cells for TRAIL-induced
caspase-8 activation in a small but highly reproducible as
well as significant manner (Figure 4c), whereas cFLIP-
repressed cells remained insensitive to TNF-induced caspase
activation or apoptosis induction (Figure 4d). Downregula-
tion of cFLIP is therefore not sufficient to sensitize for
TNF-induced cell death. Thus, we hypothesized that other
NF-kB-dependent factors may contribute to the maintenance
of TNF apoptosis resistance upstream of caspase-8 activation
in HaCaT keratinocytes.
cIAP2 is not critical for the modulation of TNF-induced
apoptosis in HaCaT keratinocytes
Although overexpression of cFLIP can inhibit apoptosis
induced by both TNF and TRAIL (Figure 4), we thought it
unlikely that this accounted for the differential sensitivity of
the IKK2-KD cells, given the fact that modulation of
physiological levels of cFLIP using siRNA was effective to
sensitize for TRAIL- but not TNF-induced apoptosis. We
therefore investigated a panel of target genes reported to be
regulated by NF-kB by RNase protection assays. The steady-
state level of cIAP2 mRNA was remarkably and specifically
downregulated in the IKK2-KD mutant cell line. Surprisingly,
none of the other presumptive NF-kB targets, such as cIAP1,
XIAP, TRAF1, or TRAF2, were downregulated (Figure 5a and
b). The protein levels of cIAP2 were also markedly reduced in
the IKK2-KD cell lines and, gratifyingly, specifically upregu-
lated in the IKK2-EE mutant cells (Figure 5c). These data,
obtained from three independent, polyclonal cell lines,
strongly supported the concept that steady-state levels of
cIAP2 are specifically regulated by NF-kB in HaCaT
keratinocytes and furthermore suggested that the key
difference that determines NF-kB-mediated resistance to
TNF would rely on the expression of cIAP2. We next tested
whether expression of IKK2-KD modulated the composition
of the protein complexes recruited to TNF or TRAIL receptors
(Figure 5d). Although ligand affinity precipitates of TNF in
control and in NF-kB-inhibited HaCaT cells contained
comparable amounts of TNF-R1, TNF receptor-associated
death domain, receptor-interacting protein, TRAF2, and
cIAP1, the amount of cIAP2 present in the TNF receptor
complex of IKK2-KD-expressing cells was drastically re-
duced. Moreover, the known TRAIL DISC components
TRAIL-R2, FADD, and caspase-8 were unchanged in the
presence of IKK2-KD. To test whether cIAP2 is indeed crucial
to maintain TNF resistance, the expression of cIAP2 was
knocked down by using stably expressed siRNA. Although
expression of siRNA1 efficiently downregulated cIAP2
(Figure 6a) compared to control-infected cells, or cells
infected with the less efficient siRNA2, modulation of cIAP2
was not sufficient to sensitize HaCaT cells to TNF-induced
apoptosis (Figure 6b). It could be argued that even though
significant knockdown of cIAP2 protein was achieved, the
extent of the downregulation was still not sufficient to
sensitize cells to TNF. We therefore sought to test the
hypothesis that cIAP2 expression is sufficient to make cells
resistant to TNF by overexpressing cIAP2 in TNF-sensitive
IKK2-KD cells, utilizing a 4-hydroxytamoxifen (4-HT)-indu-
cible construct for cIAP2 that we have developed recently.
We therefore performed sequential transduction of parental
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HaCaT cells with constructs for the 4-HT-responsive ER Gal4
VP16 transcriptional activator, the Gal4-dependent cIAP2
construct, and the retroviral IKK2-KD construct. Addition of
4-HT to these cells rapidly induced cIAP2 in a dose-
dependent manner (Figure 7a), and maximal induction was
obtained with 50–100 nM 4-HT within 4–24 hours. For the
subsequent biochemical characterization and the apoptosis
sensitivity studies, a range of 10–100 nM 4-HT was used.
IKK2-KD-expressing HaCaT cells carrying the inducible
cIAP2 construct in the absence of the 4-HT-responsive
VP16 transactivation domain (GEV16) were highly sensitive
to TNF-induced cell death independent of 4-HT (data not
shown). Expression of GEV16 alone slightly increased TNF
apoptosis resistance in response to 4-HT (Figure 7b, left
panel). The induced upregulation of cIAP2 increased relative
TNF apoptosis resistance when compared to the effect of
4-HT in GEV16-infected cells alone (Figure 7b). However,
higher cIAP2 expression levels achieved by using increased
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Figure 4. The role of cFLIP in TNF-induced apoptosis in IKK2-KD-infected HaCaT keratinocytes. (a) Pools of cFLIPL-infected cells as indicated were either
left untreated or stimulated with TRAIL or TNF (each at 1 mgml1) for 6 hours, harvested, and examined for the induction of TNF- or TRAIL-mediated cell
death. A representative experiment of three independent experiments is shown. (b) Inhibition of caspase-8 cleavage in TNF-treated IKK2-KD/c-FLIPL-expressing
HaCaT keratinocytes. cFLIPL- and IKK2-KD-expressing HaCaT keratinocytes were mock-treated or stimulated with 1 mgml
1 of TRAIL or TNF for 3 hours
and total cellular lysates were analyzed for cFLIPL, cFLIPS, caspase-8, and caspase-3. Molecular weights of full-length proteins and cleavage products are
indicated. (c) Stable retroviral siRNA expression against cFLIP sensitizes HaCaT keratinocytes for TRAIL-, but not for TNF-induced apoptosis. Upon successful
infection with the respective constructs, cells were mock-treated or treated with TRAIL or TNF (both at 1 mgml1) for 3 hours and subsequently subjected to
western blot (WB) analysis for cFLIP and caspase-8. Molecular weight of full-length proteins and cleavage products are indicated. An intentionally overexposed
blot is shown to detect low levels of cFLIP expression in shRNA-expressing cells. Tubulin served as a loading control. (d) cFLIP downregulation sensitizes HaCaT
keratinocytes for TRAIL- but not for TNF-induced apoptosis. Pools of infected cells as shown in (c) were either left untreated or stimulated with increasing
concentrations of TRAIL or TNF for 16–24hours. Cells were then harvested and viability was examined by crystal violet staining. A representative experiment of
a total of five independent experiments is shown. The sensitivity of cFLIP siRNA-infected cells to TRAIL was moderately increased in independent experiments
but in a highly reproducible manner. Two-way ANOVA analysis was performed with post hoc testing (Bonferroni). Global testing demonstrated high significance
(Po0.001) of treatment differences. Post hoc testing revealed that the difference between both cell types was insignificant for TNF treatment, whereas the
difference between cFLIP-siRNA-treated cells and control cells was significant for TRAIL treatment.
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Figure 5. Analysis of NF-jB-dependent pro- and anti-apoptotic molecules in HaCaT keratinocytes. (a and b) Control HaCaT cells and HaCaT keratinocytes
expressing either IKK2-KD or IKK2-EE were examined for mRNA expression of a panel of potential NF-kB-dependent target genes using multiprobe RNase
protection assays. Steady-state levels of the indicated genes were determined by normalizing against the expression of the L32 housekeeping gene as assessed by
PhosphoImager densitometry. (c) Steady-state protein expression of the indicated molecules was assessed by western blot analysis. Total cellular lysates were
analyzed for the indicated molecules. Molecular weight markers are shown on the left. Asterisks indicate nonspecific band detected by the respective Abs.
(d) TNF and TRAIL receptor signalling complexes in control or NF-kB-inhibited cells. HaCaT keratinocytes were stimulated with 2.5 mgml1 TNF for
15minutes or 2.5mgml1 TRAIL for 30minutes, and subsequently receptor complexes were precipitated by ligand affinity precipitation using HF-TRAIL
or HF-TNF, respectively, as described in Materials and Methods. Precipitation of TNF and TRAIL receptors following lysis () served as internal
specificity control when compared to ligand affinity precipitates (þ ). Equal amounts of total cellular lysates (lysates) or ligand affinity precipitates (IP)
were subsequently analyzed by western blotting for the indicated molecules.
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concentrations of 4-HT up to 100 nM (compare Figure 7a) did
not further increase resistance to TNF (data not shown),
thereby excluding the possibility that the incomplete protec-
tion to TNF-induced apoptosis might be due to insufficient
expression of cIAP2. In contrast, control cells with intact NF-
kB activation remained completely apoptosis-resistant using
TNF concentrations of up to 1 mgml1 (Figure 7b and data not
shown).
To investigate the function of cIAP2 for TNF signalling in
HaCaT keratinocytes in more detail, TNF receptor complexes
were precipitated in NF-kB-inhibited cells inducibly expres-
sing cIAP2. In line with the findings shown in Figure 5d and
previous reports (Harper et al., 2003; Micheau and Tschopp,
2003), TNF receptor-associated death domain, receptor-
interacting protein, and TRAF2 were found to be recruited
to the TNF receptor complex irrespective of the presence or
absence of cIAP2 (Figure 7c). In addition, cIAP1 and cIAP2
were specifically recruited to the complex, and cIAP2 levels
in the complex were increased in cells induced with 4-HT. Of
note, the increase of cIAP2 in the TNF complex was less
pronounced than the increase detected in total cellular
lysates (Figure 7c), suggesting that the affinity of cIAP2 for the
complex is weak. Alternatively, other known or unknown
adaptor proteins such as TRAF2 that are able to bind cIAP2
may be a limiting factor in this context. Future studies are
required to delineate this point in detail. Finally, inducing the
expression of cIAP2 did not alter recruitment or post-
translational modification of any of the other proteins
examined in the TNF receptor complex (Figure 7c, lanes 2,
4, 6, and 8). Our data show that although cIAP2 is induced by
TNF, surprisingly, it is unlikely to play a key role in the
resistance of HaCaT keratinocytes to TNF, raising the
important question why cIAP2 is induced by TNF. Our
studies strongly suggest that additional NF-kB-dependent
factors as yet unidentified are required to preserve TNF
resistance in HaCaT keratinocytes and that the search for
additional factors is therefore warranted. The inducible
lentiviral experimental system described in this report will
prove invaluable to study the impact of additional NF-kB-
dependent candidate molecules in the future.
DISCUSSION
TNF exerts pleiotropic functions in almost all organ systems
in a cell type-specific manner. In contrast to other death
ligands such as CD95L or TRAIL, TNF is a major proin-
flammatory mediator, with the additional option to induce
apoptosis. Both functions of TNF have been widely studied,
and the inhibition of the proinflammatory effects of TNF by a
variety of inhibitory agents is already used with marked
success for patients requiring treatment of inflammatory
diseases such as rheumatoid arthritis, inflammatory bowel
disease, or psoriasis (Jacobi et al., 2003; Choo-Kang et al.,
2005). As elimination of keratinocytes by apoptosis might
severely impact the cytokine-mediated inflammatory re-
sponses of the skin, the understanding of TNF apoptosis
sensitivity is of central importance for the understanding of
TNF-induced skin inflammation. Over the past decade, it has
been widely accepted that NF-kB proteins (such as RelA/p65,
p50, and RelB) are involved in the maintenance of apoptosis
resistance to a multitude of stimuli (Karin and Lin, 2002;
Burstein and Duckett, 2003). Our previous studies did not
reveal an important role for NF-kB in the regulation of TRAIL
apoptosis sensitivity in keratinocytes (Leverkus et al.,
2003a, b). In striking contrast, we have observed a dramatic
sensitization to TNF-mediated apoptosis when NF-kB activa-
tion is inhibited by expression of a dominant-negative IKK2
mutant. These data are in line with a number of reports that
have shown that the death-inducing function of TNF is
masked whenever the activation of NF-kB by TNF is possible
(for review, see Wajant et al., 2003). Given the importance of
TNF signalling in human keratinocytes (Banno et al., 2004),
we have investigated the regulatory mechanisms relevant for
TNF-induced apoptosis. TNF exerts its diverse biological
effects through two different receptors, and only TNF-R1
contains an intracellular death domain (Locksley et al.,
2001). In human HaCaT keratinocytes, both TNF receptors
are expressed at low levels on the cell surface. However,
there is now a broad body of evidence that TNF-induced
apoptosis is largely mediated via TNF-R1 (Micheau and
Tschopp, 2003; Wajant et al., 2003). We excluded that
interference with NF-kB activation leads to modification
of surface receptor expression. Our data showed that
expression of TNF-R1 and TNF-R2 is rather decreased in
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Figure 6. Downregulation of cIAP2 using siRNA expression. (a) Steady-state
protein levels of cIAP2, cIAP1, and tubulin were assessed by western blot
analysis. Molecular weight markers are indicated on the left.
Asterisks indicate a nonspecific band detected by the respective Abs.
(b) Downregulation of cIAP2 is not sufficient to sensitize HaCaT keratinocytes
to TNF-induced cell death. Dose-dependent induction of TNF-mediated cell
death in stable cIAP2 siRNA-expressing keratinocytes. Pools of cells infected
with either control vector, partially effective siRNA to cIAP2 (siRNA2), or
effective siRNA (siRNA1) were left untreated or stimulated with increasing
concentrations of TNF for 16–24 hours, harvested, and examined for the
induction of cell death using crystal violet assay as indicated in Materials and
Methods. The mean 7 SD of a total of two independent experiments is
shown.
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IKK2-KD-expressing HaCaT cells, despite the dramatic
increase in TNF sensitivity, and this change in sensitivity is
in line with data using a transdominant negative form of IkBa
(Micheau and Tschopp, 2003). Thus, modulation of cell-
surface TNF receptor expression is clearly not the cause for
increased TNF apoptosis sensitivity when NF-kB activation is
inhibited, despite the fact that our experimental system is
unable to distinguish constitutive versus induced NF-kB
activity and their differential role in sensitivity to TNF.
Our kinetic biochemical studies revealed that TNF-
induced initiator caspase cleavage is blocked in HaCaT
keratinocytes. Upon inhibition of NF-kB, TNF induces
detectable initiator caspase activation within 4–6 hours.
Animal studies have indicated that the sensitivity to TNF-
induced apoptosis is regulated by cFLIP (Yeh et al., 2000).
Our data show that cFLIPL and cFLIPS are induced by TNF but
not TRAIL within 4–6 hours in HaCaT keratinocytes, in line
with genome-wide screening data in primary keratinocytes
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Figure 7. Inducible upregulation of cIAP2 in TNF-sensitive IKK2-KD-expressing HaCaT keratinocytes is not sufficient to restore TNF apoptosis resistance.
(a) Inducible expression of cIAP2. Cells were transduced with a 4-HT-inducible lentiviral construct carrying cIAP2 and subsequently incubated in the
presence or absence of the indicated concentration of 4-HT for 4 (upper panel) and 24 hours (lower panel). Cells were then compared for protein expression of
cIAP2, cIAP1, and tubulin by western blotting. Vector-infected (Vector) and IKK2-KD-infected cells (IKK2-KD) served as control for cIAP2 expression.
Asterisks indicate the nonspecific band detected by the respective Abs. (b) Inducible upregulation of cIAP2 is not sufficient to restore resistance to TNF-induced
cell death. Pools of cells infected with the inducible lentiviral construct together with GEV16 (GEV16/cIAP2) or the GEV16 construct alone (GEV16) were
infected with control vector or IKK2-KD and subsequently analyzed for TNF-induced cell death in the presence or absence of 20 nM 4-HT. Cells were harvested
24hours later and viability was assessed by crystal violet staining. The mean7SD of a total of two independent experiments is shown. (c) TNF receptor signalling
complexes in control and NF-kB-inhibited HaCaT keratinocytes in the presence and absence of cIAP2. HaCaT keratinocytes transduced with the inducible
lentiviral construct together with GEV16 and followed by transduction with IKK2-KD or control vector as indicated in (b) were treated with 4-HT (50 nM) or
diluent alone for 4 hours. Cells were subsequently stimulated with 2.5 mgml1 TNF for 15minutes, and TNF receptor complexes were precipitated as described
in Materials and Methods. Precipitation of TNF receptors following lysis () served as an internal specificity control when compared to ligand affinity
precipitates (þ ). Equal amounts of total cellular lysates (lysates) or ligand affinity precipitates (IP) were subsequently analyzed by western blotting for the
indicated molecules. Asterisks indicate nonspecific band detected by the respective Abs. Molecular weights are indicated on the left.
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(Banno et al., 2004). This TNF-dependent induction of cFLIP
was absent in NF-kB-inhibited cells, whereas basal cFLIP
levels remained unchanged. These data confirm that TNF-
induced NF-kB activation regulates cFLIP expression (Kreuz
et al., 2001; Micheau et al., 2001) and, despite similar early
activation of NF-kB by TRAIL and TNF (compare Figure 1b),
TNF appears to be a more potent inducer of cFLIP, indicating
that signalling pathways other than NF-kB activated by TNF
might be crucial for sustained gene induction. Because cFLIP
is a short-lived protein (Leverkus et al., 2000; Wajant et al.,
2000; Micheau et al., 2001), our data suggest that additional
signals might be required for increasing cFLIP levels, such as
mRNA stability or protein degradation. Interestingly, cFLIPL
cleavage to p43 is obtained when NF-kB activation in
response to TNF is blocked (Figure 4). These results indicate
that whenever NF-kB is inhibited, an intracellular complex
that allows cFLIP and/or caspase-8 activity can form and that
it is not formed when TNF-induced NF-kB activation can
proceed.
We showed, in line with many other results, that high
levels of cFLIP are sufficient to protect NF-kB-inhibited cells
against TNF-induced cell death. Thus, cFLIP might confer
TNF resistance to HaCaT keratinocytes in line with data in
primary keratinocytes (Banno et al., 2005). The HaCaT
keratinocytes used for our study express only very low
endogenous levels of cFLIP when compared to primary
keratinocytes (Leverkus et al., 2000). Further depletion of this
low level of steady-state cFLIP further sensitizes cells to TRAIL
but fails to sensitize cells to TNF-induced apoptosis. Thus,
our data reveal a striking difference for cFLIP apoptosis
protection in TRAIL- versus TNF-induced apoptosis. It will be
interesting to examine additional signals activated by TRAIL
and TNF receptors in keratinocytes, such as the activation of
NF-kB and c-Jun-N-terminal kinase. This might be particu-
larly interesting in the context of high or low levels of cFLIP,
which may not only alter caspase-8 cleavage but may rather
modulate activation of NF-kB selectively by TRAIL but not by
TNF, as indicated recently (Wachter et al., 2004; Varfolo-
meev et al., 2005). Whether these signalling pathways indeed
play a role in protection against apoptosis or whether they
may alter gene induction by these ligands needs to be
determined in future studies. Notably, NF-kB-dependent
induction of cFLIP is counteracted by degradation, recently
shown to be mediated by c-Jun-N-terminal kinase-mediated
activation of the E3 ubiquitin ligase Itch (Chang et al., 2006).
Although our study clearly demonstrates that cFLIP is not the
critical regulator of TNF apoptosis resistance in human skin,
future studies including organ-specific knockout models for
cFLIP (Zhang and He, 2005) will have to clarify the physiological
importance of cFLIP deficiency for TNF and TRAIL apoptosis
resistance as well as gene induction in the skin in vivo.
Current models —based on the concerted overexpression
of the NF-kB target molecules TRAF1, TRAF2, cIAP1, and
cIAP2—suggest that these molecules are relevant for TNF-
mediated apoptosis (Wang et al., 1998). More recent data
indicate that neither cIAP1 nor cIAP2 is able to inhibit
caspases directly (Eckelman and Salvesen, 2005). Thus, the
exact role of cIAP1 or cIAP2 in TNF-induced cell death is still
unclear to date. To investigate these contradictory findings in
our experimental system, we examined the expression of a
larger panel of potential NF-kB target genes including these
four genes. Interestingly, only the cIAP2 expression level was
significantly modulated at the mRNA and protein levels in
TNF-sensitive HaCaT keratinocytes in which basal and death
ligand-mediated NF-kB activity was blocked. Thus, cIAP2
represented a likely candidate for the regulation of TNF
resistance in keratinocytes. To further test the relevance of
cIAP2, we subsequently performed siRNA studies to selec-
tively interfere with cIAP2 expression. However, these studies
did not demonstrate sensitization of HaCaT keratinocytes to
TNF-induced apoptosis, despite effective downregulation of
cIAP2 at the mRNA and protein level. cIAP2 is induced
dramatically by TNF in a number of cell types (Varfolomeev
et al., 2005) as well as in HaCaT keratinocytes within
4–6 hours (Figure S2c). However, our data demonstrate that
cIAP2 is not crucial for the maintenance of TNF resistance, at
least in HaCaT keratinocytes. To rule out that siRNA
effectiveness was not high enough for a decrease of cIAP2
mRNA levels and to circumvent potential experimental
problems that could arise during clonal selection, we
employed a 4-HT-inducible system to test the impact of
cIAP2 expression in the context of TNF-sensitive, NF-kB-
inhibited HaCaT cells (Figure 7). These findings clearly
demonstrated that cIAP2 is not sufficient to maintain
TNF resistance in HaCaT cells, although we were able to
detect a moderate dose-dependent protection by cIAP2
expression when compared to control infected cells (compare
Figure 7b). This protective effect could, however, not be
further increased by higher expression levels of cIAP2
(compare Figure 7a), suggesting that cIAP2 is not critical for
the modulation of TNF-induced apoptosis. It has been
suggested previously that compensatory expression of cIAP1
or XIAP might explain the largely absent phenotype in XIAP
knockout mice (Harlin et al., 2001). As IAP2 levels are
regulated by the ubiquitin protein ligase activity of cIAP1
(Conze et al., 2005; Vaux and Silke, 2005), we also studied
whether expression of IKK2-KD with consequent loss of
cIAP2 protein expression altered expression of cIAP1.
However, our data excluded that compensatory expression
of cIAP1 could explain TNF-induced cell death in IKK2-KD-
expressing HaCaT cells (compare Figures 6 and 7). Future
studies will hopefully reveal why cIAP2 is such a highly
regulated protein in human keratinocytes and why cIAP2 is
not sufficient to maintain TNF apoptosis resistance. Our study
thus highlights an interesting conundrum and suggests a more
complex role for cIAP2 than previously thought.
Our experimental system has certain limitations. First, it
has been suggested that NF-kB signalling is not identical
when comparing HaCaT keratinocytes to primary keratino-
cytes. Thus, future comparative studies with primary cells will
prove to be highly interesting with respect to TNF apoptosis
resistance (Chaturvedi et al., 2001; Lewis et al., 2006).
Moreover, there might be dynamic changes of NF-kB target
genes that we are unable to detect owing to the fact that
stable expression of IKK2-KD downregulates constitutive as
well as TNF-induced target genes (compare Figure S1c).
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Second, the fact that inducible expression of IKK2-KD or
IKK2-EE mutants in HaCaT keratinocytes recapitulates our
findings with stable expression of IKK2 mutants is indicative
of the physiological relevance of our data (Figure S3).
Nonetheless, future studies will have to investigate what
other known or unknown target genes of NF-kB are critical to
maintain TNF apoptosis resistance other than cIAP2. Most
likely, these studies may require a genome-wide approach or
the use of inducible abrogation of NF-kB function, as
performed previously in a mouse model or as feasible with
inducible IKK mutants (Stratis et al., 2006).
As cIAP2 is not responsible for apoptosis resistance to
TNF, what could be its physiological role in the skin? Recent
reports have suggested that cIAP2 might be more important
for proinflammatory signals initiated by other surface
receptors such as Toll-like receptors (Conte et al., 2006) In
particular, cIAP2 knockout cells that do not change sensitivity
to CD95L-induced apoptosis have a markedly increased
sensitivity to lipopolysaccharide-induced apoptosis, but do
not show any overt phenotype under physiological condi-
tions (Conte et al., 2006). Because contamination of
lipopolysaccharide as the cause of TNF-induced cell death
in our preparations is highly unlikely (Figure 3b), our data
clearly indicate cell type as well as stimulus-specific
differences that might dramatically alter the outcome of
TNF receptor triggering in different organ systems. Our results
support the hypothesis that cIAP1 or cIAP2 may have a role in
the amplification of proinflammatory pathways that secon-
darily activate an NF-kB-dependent anti-apoptotic response
rather than acting as direct anti-apoptotic caspase-inhibitory
molecules. Future studies examining interaction partners of
cIAP2 following TNF stimulation in keratinocytes are thus
required to delineate these points in more detail. To this end,
post-translational modifications of cIAP1 or cIAP2 might be
crucial for their signalling capabilities in the context of TNF
receptor triggering (Vaux and Silke, 2005). The fact that
cIAP2 is not sufficient to maintain apoptosis resistance to TNF
in NF-kB-inhibited cells may thus stimulate future studies
using the experimental system described in this report that
will investigate the contribution of other NF-kB-regulated
molecules for the protection against TNF-mediated apoptosis.
MATERIALS AND METHODS
Materials
The following antibodies (Abs) were used: Abs to caspase-8 (C15),
cFLIP (NF-6; Alexis, San Diego, CA), FADD (Transduction Labora-
tories, San Diego, CA), IkBa (C-21), TNF-R1 (H-5), TRAF2 (C-20;
from Santa Cruz Biotechnology Inc., Santa Cruz, CA), CPP32 (kindly
provided by D.W. Nicholson, Merck Frost, QC, Canada), and RIP-1
and TRADD (Becton Dickinson, Heidelberg, Germany). Abs to IKK2
(Ab 2684) were from New England Biolabs (Boston, MA), Abs to
TRAIL-R2 (anti-DR5) were from Sigma (Saint Louis, MO), and Abs to
cIAP2 were from R&D Systems Inc. (Minneapolis, MN). mAbs to
TNF-R1 (H398) and a rabbit antiserum specific for TNF-R2 for cell-
surface stainings were generously provided by H. Wajant (Institute
for Molecular Medicine, University of Wu¨rzburg, Germany). Rat
anti-cIAP1 mAbs were generated as described recently (Silke
et al., 2005). For expression of His-FLAG-TRAIL (HF-TRAIL) and
His-FLAG-TNF (HF-TNF), the complementary DNAs encoding the
extracellular domain of TRAIL (aa95–281) or TNF (aa78–233) were
N-terminally fused to a FLAG tag (DYKDDDDK) by PCR cloning and
ligated into the BamHI- and NotI-restricted pQE32 vector (Qiagen,
Hilden, Germany). The proteins were expressed in Escherichia coli
M15 (pREP4) (Qiagen) at 181C overnight and purified using a
standard Ni-NTA column (Qiagen). Protein purity (495%) and
integrity were verified by SDS-PAGE and Coomassie staining.
Bioactivity of HF-TRAIL and HF-TNF was confirmed by apoptosis
assays in Jurkat J16 and U937 cells, respectively. Ligand-mediated
cell death was completely blocked by addition of either soluble
TRAIL-R2-Fc protein or TNF-R2-Fc protein, respectively. Recombi-
nant leucine zipper TRAIL was generated as described (Walczak
et al., 1999). Horseradish peroxidase -conjugated donkey anti-rabbit
and goat anti-mouse IgG Abs were from Pharmingen (Hamburg,
Germany), and horseradish peroxidase-conjugated goat anti-mouse
IgG1, IgG2a, IgG2b, and IgG1k were obtained from Southern
Biotechnology Associates (Birmingham, AL). TRAIL-R1 (HS 101),
TRAIL-R2 (HS 201), TRAIL-R3 (HS 301), and TRAIL-R4 (HS 402)
mAbs for FACScan analysis of surface receptor expression were used
as described (Leverkus et al., 2003b) and are available from Alexis
(San Diego, CA). Recombinant human TNF was obtained from
Strathmann Biotech (Hannover, Germany). 4-HT was from Sigma-
Aldrich (Steinheim, Germany). TNF-R2-Fc was provided by Wyeth
Pharma (Mu¨nster, Germany).
Cell culture
The spontaneously transformed keratinocyte line HaCaT was kindly
provided by Dr N. Fusenig (DKFZ, Heidelberg, Germany) and
cultured as described (Boukamp et al., 1988).
Retroviral infection
The pCFG5-IEGZ retroviral vector containing complementary DNA
inserts of IKK2-KD or IKK2-EE (Denk et al., 2001; Azoitei et al.,
2005) was used for infection of HaCaT keratinocytes. Briefly, the
amphotrophic producer cell line jNX was transfected with 10 mg of
the retroviral vectors by calcium phosphate precipitation. To select
transfected producer cells, 1mgml1 puromycin (Sigma, Taufkirch-
en, Germany) or 0.5 mgml1 zeocin was added to the culture
medium for 7–14 days to obtain 495% green fluorescent protein -
positive producer cells. Cell culture supernatants containing viral
particles were generated by incubation of producer cells with HaCaT
medium (DMEM containing 10% fetal calf serum) overnight.
Following filtration (45mm filter; Schleicher & Schuell, Dassel,
Germany), culture supernatant was added to HaCaT cells seeded in
six-well plates 24hours earlier in the presence of 1mgml1 polybrene.
HaCaT cells were centrifuged for 3hours at 211C, and viral particle
containing supernatant was subsequently replaced by fresh medium.
After 10–14 days recovery of bulk-infected cultures, FACS analysis for
green fluorescent protein expression (data not shown) and western blot
analysis (Figure 1) was performed on expanded polyclonal cells to
confirm ectopic expression of the respective molecules. For sequential
transduction with IKK2-KD and cFLIPL, cells were first infected with
cFLIPL or control vector exactly as described recently (Wachter et al.,
2004) and subsequently infected with either IKK2-KD or the respective
empty construct. Aliquots of cells were used for the experiments
between passages 1 and 10 postinfection for cytotoxicity assays and
biochemical characterization.
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Stable siRNA expression
We used stable expression of siRNA as published previously
(Brummelkamp et al., 2002). For generation of the constructs,
complementary DNA 64-mer oligomers containing either cIAP2 or
cFLIP targeting sequences (for cIAP2, nucleotide start position þ 316:
50-gatccccGAAGCTACCTCTCAGCCTAttcaagaga TAGGCTGAGAG
GTAGCTTCtttttggaaa-30 and nucleotide start position þ 466: 50-gatcc
ccGCCTTGATGAGAAGTTCCTttcaagagaAGGAACTTCTCATCAAGGC
tttttggaaa-30 were used; for cFLIP, nucleotide start position þ 911: gat
ccccGGAGCAGGGACAAGTTACAttcaagagaTGTAACTTGTCCCTGCT
CCtttttggaaa was employed) were cloned into the pSuper.retro retroviral
vector using HindIII and BglII restriction sites. The resulting vectors or
control empty vector was transfected into the amphotrophic producer
cell line exactly as described above (Leverkus et al., 2003b; Wachter
et al., 2004). The retrovirus-containing supernatant was then used to
infect HaCaT cells, and infected HaCaT cells were selected by
puromycin (1mgml1) for 3–14 days to obtain puromycin-resistant
bulk-infected cultures for further analysis.
Lentiviral infection
To generate cells expressing 4-HT-inducible cIAP2, HaCaT cells
were transduced with a lentivirus pF GEV16 Super PGKHygro,
which expresses a Gal4 DNA binding domain fused to a mutant
estrogen receptor and GEV16, and a lentivirus pF 5UAS hs cIAP2
W SV40 Puro, which expresses cIAP2 in a Gal4-dependent fashion
(cIAP2). To generate lentiviral supernatants, 293T cells were
transfected with 3mg pMD2.G, 5 mg pMDlg/pRRE, and
2.5 mg pRSV-Rev of the lentiviral packaging vectors (Rubinson
et al., 2003) together with the constructs described above. The
supernatants were harvested 24 hours post-transfection, filtered
(45 mm filter, Schleicher & Schuell), and concentrated by centrifuga-
tion (19,500 g, 2 hours at 121C). The concentrated virus was added
to HaCaT cells with 5 mgml1 polybrene, and HaCaT cells were
spin-infected. Stable cell lines were selected in hygromycin
(100–150mgml1), puromycin (1mgml1), or both. Certain lines
were subsequently infected with retrovirus containing IKK2-KD or
control vector as described above and selected with zeocin
(300mgml1) for 14 days.
FACScan analysis
For surface staining of TRAIL receptors (TRAIL-R1 to TRAIL-R4) and
TNF receptors (TNF-R1 and TNF-R2), cells were trypsinized and
2 105 cells were incubated with mAbs against TRAIL-R1 to TRAIL-
R4, TNF-R1 and TNF-R2, or isotype-matched control IgG
for 30minutes followed by incubation with biotinylated goat
anti-mouse or biotinylated goat anti-rabbit secondary Abs (BD
Pharmingen, Heidelberg, Germany) and Cy5-phycoerythrin-labelled
streptavidin (Caltag, Burlingame, CA) as described (Wachter et al.,
2004). For all experiments, 104 cells were analyzed by FACScan
(Becton Dickinson & Co, San Jose, CA).
Ligand affinity precipitation of receptor complexes
For the precipitation of the TRAIL DISC or the TNF complex, 5 106
HaCaT keratinocytes were used for each condition. Cells were
washed once with DMEM medium at 371C and subsequently
incubated for the indicated time periods at 371C in the presence of
either 2.5 mgml1 HF-TRAIL pre-complexed with 5mgml1 anti-
FLAG M2 (Sigma, Taufkirchen, Germany) for 30minutes or 2.5mg/ml
HF-TNF pre-complexed with 5 mgml1 anti-FLAG M2 for 15min-
utes, or, for the unstimulated control, in the absence of ligands.
Receptor complex formation was stopped by washing the monolayer
four times with ice-cold phosphate-buffered saline. Cells were lysed
on ice by the addition of 2ml lysis buffer (30mM Tris-HCl (pH 7.5) at
211C, 120mM NaCl, 10% glycerol, 1% Triton X-100, Complete
protease inhibitor cocktail (Roche Molecular Diagnostics, Man-
nheim, Germany)). After 15minutes of lysis, the lysates were
centrifuged at 20,000 g for 30minutes to remove cellular debris.
A minor fraction of this lysate was used to control the input of the
respective proteins. Receptor complexes were precipitated from the
lysates by co-incubation with 40 ml of protein G beads (Roche) for
48 hours on an end-over-end shaker at 41C. For precipitation of the
non-stimulated receptors, 50 ng of either HF-TNF or HF-TRAIL pre-
complexed with anti-FLAG M2 antibody as indicated above was
added to the lysates prepared from non-stimulated cells to control
protein association with non-stimulated receptor(s). Ligand affinity
precipitates were washed five times with lysis buffer before the
protein complexes were eluted from the dried beads by the addition
of standard reducing sample buffer and boiling at 951C. Subse-
quently, proteins were separated by SDS-PAGE on 4–12% NuPAGE
gradient gels (Invitrogen, Karlsruhe, Germany) before detection of
receptor complex components by western blot analysis.
Western blot analysis
Cell lysates were prepared essentially as described before (Leverkus
et al., 2003b). Subsequently, 5–20 mg of proteins was separated by
SDS-PAGE on 4–12% NuPAGE Bis-Tris gradient gels (Invitrogen)
and transferred to nitrocellulose or polyvinylidene difluoride
membranes. Blocking of membranes and incubation with the
indicated primary and appropriate secondary Abs were performed
essentially as described elsewhere (Leverkus et al., 2003a; Wachter
et al., 2004). Bands were visualized with the enhanced chemical
luminescence detection kit (Amersham, Freiburg, Germany).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay was performed using nuclear
extracts of HaCaT keratinocytes as described previously (Marienfeld
et al., 2001; Leverkus et al., 2003a). The oligonucleotide probe used
was a consensus NF-kB binding site derived from the kB element of
the IL-2 promoter (‘‘TCEdA4C’’): 50-CTAAATCCCCACTTTAGGGA
GAACCAG-30.
RNase protection assays
Total RNA was extracted using TRIzol reagent (Life Technologies,
Gaithersburg, MD) and processed using Pharmingen’s RNase
protection assay system (hAPO-5, hAPO-3d) according to the
manufacturer’s instructions. Image data were collected with a
PhosphoImager (Fuji Photo, Du¨sseldorf, Germany).
Apoptosis and cytotoxicity assays
Crystal violet staining of attached, living cells was performed
16–24hours after stimulation with different concentrations of TRAIL
or TNF in 96-well plates with the indicated concentrations as
described (Leverkus et al., 2000) in duplicate or triplicate wells per
condition. The optical density of control cultures was normalized as
100% to compare independent experiments. Subdiploid DNA
content was analyzed as described by Nicoletti et al. (1991). Briefly,
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cells from a 35mm dish were cultured until they reached 70%
confluence and were subsequently stimulated for 6 hours. Cells were
then detached, washed with cold phosphate-buffered saline, and
resuspended in buffer N (0.1% (w/v) sodium citrate, 0.1% (v/v) Triton
X-100, 50 mgml1 propidium iodide). Cells were kept in the dark at
41C for 48 hours and diploidy was measured by FACScan analysis.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank P.H. Krammer for providing mAbs to caspase-8 (C-15) and cFLIP
(NF-6), and D.W. Nicholson for providing CPP32 (caspase-3) antiserum. We
are grateful to L. van Parijs for providing lentiviral packaging constructs and
H. Wajant for providing reagents and for critical reading of the manuscript.
M.R. Sprick is supported by an EMBO Long Term fellowship. We thank E.
Horn, S. Pietzke, K. Garzinski, and M. Mo¨ckel for excellent technical
assistance and B. Peters for statistical analysis. Part of this study was funded by
grants from the Wilhelm-Sander-Stiftung (2000.092.2), Deutsche Krebshilfe
(106849), Exzellenzfo¨rderung Sachsen-Anhalt (N2_OGU, TP6) and DFG
(Le 953/5-1) to M. Leverkus. J. Silke is funded by an NHMRC career
development grant.
SUPPLEMENTARY MATERIAL
Supplementary Materials and Methods.
Figure S1. TNF- or TRAIL-induced NF-kB activation in HaCaT keratinocytes.
Figure S2. TRAIL-R, TNF-R, and XIAP levels, as well as constitutive and
TNF-induced expression of cIAP2, in IKK2 mutant-expressing HaCaT
keratinocytes.
Figure S3. Inducible expression of IKK2 mutants recapitulates results using
constitutive expression of IKK2 mutants.
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